| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/6/2024 | $40.00 | Overweight | JP Morgan |
| 10/9/2024 | $50.00 | Buy | UBS |
| 9/11/2024 | $45.00 | Buy | Citigroup |
| 6/28/2024 | $35.00 | Outperform | Macquarie |
SC 13G - PACS Group, Inc. (0002001184) (Subject)
SC 13G - PACS Group, Inc. (0002001184) (Subject)
SC 13G - PACS Group, Inc. (0002001184) (Subject)
PACS Group, Inc. (NYSE:PACS) ("PACS") is proud to announce that 36 of its affiliated post-acute communities have been named by U.S. News & World Report to their list of Best Nursing Homes for 2025. Those communities are as follows: Community Name Location All Saints Maubert San Leandro, CA All Saints Subacute & Transitional Care San Leandro, CA Balboa Nursing & Rehabilitation Center San Diego, CA Bel Vista Healthcare Center Long Beach, CA Brushy Creek Post Acute Greer, SC Canyon Vista Post Acute Las Vegas, NV Central Gardens Post Acute San Francisco, CA Citrus Heights Post Acute
PACS Group, Inc. (NYSE:PACS) ("PACS") is proud to announce that 17 of its post acute communities have been named by Newsweek Magazine to their Best Nursing Homes for 2025. Those communities are as follows, listed in order by their state, and then their ranking in their state by category: Community Name State Ranking Category Apache Junction Health Center Arizona Fifth Over 150 beds Ridgecrest Post Acute Arizona Eighth Over 150 beds Escondido Post Acute California 15th Over 150 beds Rossmoor Post Acute California 17th Over 150 beds
Postpones Third Quarter 2024 Financial Results Conference Call PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable. "PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Jason Murray, PACS's Chief Executive Officer. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard – in how we serve our patients, op
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") announced today that independently operated subsidiaries of the Company have acquired the operations of 8 skilled nursing facilities in Pennsylvania. The facilities are located in the western Pennsylvania cities of Pittsburgh, Bedford, Bethel Park, Monroeville, and McMurray, and collectively comprise 1,199 skilled nursing beds. Four of the facilities are being leased from an affiliate of CareTrust REIT (NYSE:CTRE), and subsidiaries of the Company acquired the real estate of the remaining four facilities. "We're excited to enter into Pennsylvania — a new market for PACS and our 17th state — and we're pleased to welcome these 8 facilitie
PACS Group, Inc. (NYSE:PACS) ("PACS Group" or the "Company"), today announced that it will release its third quarter 2024 financial results after market close on Thursday, November 7, 2024. Management will host a call on Thursday, November 7, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or https://event.choruscall.com/mediaframe/webcast.html?webcastid=ngVWINHF or by dialing 877-407-0621 / +1 215-268-9899. A recording of the call will be available for replay via the website for
CareTrust REIT, Inc. (NYSE:CTRE) announced today that, together with a joint venture partner, it has entered into a binding agreement to acquire a portfolio of skilled nursing facilities for a purchase price of approximately $500 million. The portfolio consists of 31 skilled nursing facilities and a total of 3,290 licensed beds, with 30 of the facilities located in Tennessee and 1 in Alabama. The acquisition is subject to customary closing conditions, and there can be no assurance that the transaction will close in the anticipated timeframe, or at all. The Company anticipates that the transaction will close in the fourth quarter of 2024. It is anticipated that most of the facilities will b
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") announced today that independent operating subsidiaries of the Company have agreed to acquire the operations of 12 skilled nursing facilities in Tennessee, and collectively comprise 1,310 skilled nursing beds. The facilities will be leased from an affiliate of CareTrust REIT (NYSE:CTRE), pursuant to the terms of a long-term, triple net lease. The lease includes options for us to purchase the real estate on six of the facilities, between years four and seven of the lease. "Tennessee has been an attractive market for PACS for some time, and we're grateful for this opportunity to bring our model of post-acute care to the Volunteer State.
National Post-Acute Platform Adds 53 Facilities, Five New States and Senior Living Vertical to Portfolio PACS Group, Inc. (NYSE:PACS) ("PACS") has finalized its acquisition of operations of 53 skilled nursing, assisted and independent living facilities from Prestige Care (Prestige), bringing its proven model to new geographical areas. The facilities span eight western states with 21 facilities in Oregon, 19 in Washington, six in Idaho, three in Nevada and one facility each in Alaska, Arizona, California and Montana. Collectively, the facilities comprise 2,511 skilled nursing beds and 1,334 assisted living and independent living units. "PACS is committed to growing as a legacy company. O
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced the closing of its upsized underwritten public offering of 19,034,482 shares of its common stock, which includes (i) 2,777,778 shares of its common stock sold by the Company and (ii) 16,256,704 shares of common stock sold by certain selling stockholders, which includes the exercise in full by the underwriters of their 30-day option to purchase an additional 2,482,758 shares of common stock from the selling stockholders, at a public offering price of $36.25 per share, for total gross proceeds of approximately $101 million to the Company and approximately $589 million to the selling stockholders, before deducting underwrit
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced the pricing of its upsized underwritten public offering of 16,551,724 shares of its common stock, which includes 2,777,778 shares of common stock sold by the Company and 13,773,946 shares of common stock sold by certain selling stockholders, at a public offering price of $36.25 per share, for total gross proceeds of approximately $101 million to the Company and approximately $499 million to the selling stockholders, before deducting underwriting discounts and commissions and offering expenses. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,482,758 sha
JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00
UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00
Citigroup resumed coverage of PACS Group with a rating of Buy and set a new price target of $45.00
Macquarie initiated coverage of PACS Group with a rating of Outperform and set a new price target of $35.00
Postpones Third Quarter 2024 Financial Results Conference Call PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable. "PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Jason Murray, PACS's Chief Executive Officer. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard – in how we serve our patients, op
PACS Group, Inc. (NYSE:PACS) ("PACS Group" or the "Company"), today announced that it will release its third quarter 2024 financial results after market close on Thursday, November 7, 2024. Management will host a call on Thursday, November 7, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or https://event.choruscall.com/mediaframe/webcast.html?webcastid=ngVWINHF or by dialing 877-407-0621 / +1 215-268-9899. A recording of the call will be available for replay via the website for
PACS Group, Inc. (NYSE:PACS) ("PACS Group" or the "Company"), today announced that it will release its second quarter 2024 financial results after market close on Monday, August 12, 2024. Management will host a call on Monday, August 12, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240806841957/en/PACS headquarters in Farmington, Utah. (Photo: Business Wire) PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://IR.pacs.com, or https://e
4 - PACS Group, Inc. (0002001184) (Issuer)
4 - PACS Group, Inc. (0002001184) (Issuer)
Truist Securities analyst David Macdonald maintains PACS Group (NYSE:PACS) with a Buy and raises the price target from $32 to $36.
In the preceding three months, 11 analysts have released ratings for PACS Group (NYSE:PACS), presenting a wide array of perspectives from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 8 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 3 7 0 0 0 3M Ago 0 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $31.36, a high estimate of $35.00, and a low estimate of $27.00. Observing
Macquarie analyst Tao Qiu initiates coverage on PACS Group (NYSE:PACS) with a Outperform rating and announces Price Target of $35.
Gainers Anitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. Oragenics (AMEX:OGEN) shares increased by 4.24% to $2.04. The market value of their outstanding shares is at $9.1 million. PACS Group (NYSE:PACS) shares rose 3.95% to $31.52. The market value of their outstanding shares is at $4.8 billion. MultiPlan (NYSE:MPLN) shares moved upwards by 3.49% to $0.45. The market value of their outstanding shares is at $290.3 million. Nanoviricides (AMEX:NNVC) stock moved upwards by 2.01% to $2.48. The market value of their outstanding shares is at $29.2 million. Calidi Biotherapeutics (AME
The operations are located in 8 states, including Oregon (21 facilities), Washington (19 facilities), Idaho (6 facilities), Nevada (3 facilities), and one facility in each of Alaska, Arizona, California and Montana. Collectively, the facilities comprise 2,511 skilled nursing beds and 1,334 assisted living and independent living units. The Company will lease 37 of the facilities from a joint venture in which it owns a 25% interest. The remaining 16 facilities will be leased from unaffiliated third-party landlords.
Truist Securities analyst David Macdonald maintains PACS Group (NYSE:PACS) with a Buy and maintains $32 price target.
RBC Capital analyst Ben Hendrix maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $30 to $32.
Oppenheimer analyst Michael Wiederhorn maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $31 to $32.
8-K - PACS Group, Inc. (0002001184) (Filer)
NT 10-Q - PACS Group, Inc. (0002001184) (Filer)
8-K - PACS Group, Inc. (0002001184) (Filer)
424B4 - PACS Group, Inc. (0002001184) (Filer)
EFFECT - PACS Group, Inc. (0002001184) (Filer)
S-1MEF - PACS Group, Inc. (0002001184) (Filer)
S-1 - PACS Group, Inc. (0002001184) (Filer)
8-K - PACS Group, Inc. (0002001184) (Filer)
10-Q - PACS Group, Inc. (0002001184) (Filer)
8-K - PACS Group, Inc. (0002001184) (Filer)